Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Express Scripts Holding Co    ESRX   US30219G1085

Delayed Quote. Delayed Nasdaq - 05/26 04:00:00 pm
89.08 USD   -1.50%
05/26DJNew Push Ties Cost of Drugs to How Well They Work
05/23 EXPRESS SCRIPTS : Cancer doctors sound alarm over crushing costs of ..
05/21DJFor CVS, Big Bet On Pricey Medicines
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales93 858104 099100 887105 035107 570112 656
Operating income (EBITDA)5 3956 6646 8037 0447 3117 586
Operating profit (EBIT)5 1286 2956 4336 6186 8627 187
Pre-Tax Profit (EBT)2 1913 030----
Net income1 3131 8452 0082 4912 8293 220
EPS ( $)1,762,252,643,644,425,46
Dividend per Share ( $)------
Yield------
Announcement Date02/18/2013
09:01pm
02/20/2014
09:48pm
02/23/2015
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt13 12111 95611 73512 12011 50310 729
Finance------
Operating income (EBITDA)5 3956 6646 8037 0447 3117 586
Leverage
(Debt/EBITDA)
2,43x1,79x1,73x1,72x1,57x1,41x
Capital Expenditure160423437355427455
Book Value Per Share (BVPS)28,6 $28,2 $27,6 $25,4 $24,9 $24,6 $
Cash Flow per Share6,36 $5,80 $5,99 $7,00 $8,34 $9,07 $
Announcement Date02/18/2013
09:01pm
02/20/2014
09:48pm
02/23/2015
09:01pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 64 965 M$ -
Entreprise Value (EV) 77 086 M$ 76 468 M$
Valuation 2015e 2016e
PER (Price / EPS) 24,5x 20,1x
Capitalization / Revenue 0,62x 0,60x
EV / Revenue 0,73x 0,71x
EV / EBITDA 10,9x 10,5x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 3,50x 3,57x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 6,30% 6,38%
operating Leverage (Delta EBIT / Delta Sales) 0,70x 1,53x
Net Margin (Net Profit / Revenue) 2,37% 2,63%
ROA (Net Profit / Asset) 6,32% 6,90%
ROE (Net Profit / Equities) 18,0% 22,0%
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   0,34% 0,40%
Cash Flow / Sales (Taux d'autofinancement) 4,86% 5,66%
Capital Intensity (Assets / Sales) 0,38x 0,38x
Financial Leverage (Net Debt / EBITDA) 1,72x 1,57x
Price Earning Ratio
EPS & Dividend